Literature DB >> 15664595

The hormonal and inflammatory responses to pelvic reconstructive surgery following major trauma.

G Nicholson1, J Woodfine, A E Bryant, I A Macdonald, M D Bircher, R M Grounds, G M Hall.   

Abstract

Patients undergoing trauma sustain an initial injury followed by further physiological challenges during surgery. Plasma osteocalcin (OC), a marker of osteoblastic activity, declines after major surgery. Increased cortisol secretion, and other components of the perioperative stress response, may play a role in mediating this response. We have examined the osteocalcin, hormonal and cytokine responses in twenty patients undergoing post-traumatic pelvic reconstruction surgery. We measured plasma osteocalcin, serum cortisol, bone specific alkaline phosphatase (BSAP), IL-6, IL-8, IL-10, plasma epinephrine and norepinephrine concentrations for up to 3 days after surgery. We recorded an increase in IL-6, IL-10 and epinephrine concentrations perioperatively and a fall in OC and BSAP concentrations. There were no significant changes in cortisol or IL-8 concentrations. Patients undergoing pelvic reconstruction surgery following trauma have a preserved inflammatory and catecholamine response but the cortisol response may be obtunded. Osteocalcin concentrations are affected by factors other than glucocorticoids.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15664595     DOI: 10.1016/j.injury.2004.07.037

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  2 in total

Review 1.  [The importance of cytokines in the posttraumatic inflammatory reaction].

Authors:  F Hildebrand; H-C Pape; C Krettek
Journal:  Unfallchirurg       Date:  2005-10       Impact factor: 1.000

2.  Effect of preoperative pregabalin on analgesia and interleukins after lumbotomy: prospective, randomized, comparative, double-blind study.

Authors:  Ana Ellen Queiroz Santiago; Plinio da Cunha Leal; Ed Carlos Rey Moura; Reinaldo Salomão; Milena Karina Coló Brunialti; Rioko Kimiko Sakata
Journal:  J Pain Res       Date:  2019-01-11       Impact factor: 3.133

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.